Retrospective review of delayed adverse events secondary to treatment with a smooth, cohesive 20-mg/mL hyaluronic acid filler in 4500 patients

Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4

Christian Termeer, Frauke Benedix, Jonathan P. Sleeman et al. · The Journal of Experimental Medicine · 2002 · 1.4K citations · Full text

Life Sciences, Immunology, Pathobiology +17

Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2

Kara Scheibner, Michael A. Lutz, Sada Boodoo et al. · The Journal of Immunology · 2006 · 698 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Oligosaccharides of Hyaluronan Are Potent Activators of Dendritic Cells

Christian Termeer, Jörn Hennies, Ursula Voith et al. · The Journal of Immunology · 2000 · 386 citations · Full text

Life Sciences, Biochemistry, Immunology +17

Evaluation of the safety of a non‐animal stabilized hyaluronic acid (NASHA – Q‐Medical, Sweden) in European countries: a retrospective study from 1997 to 2001

P. André · Journal of the European Academy of Dermatology and Venereology · 2004 · 174 citations

Medicine, Dermatology, Allergy +16

Delayed-Onset Nodules Secondary to a Smooth Cohesive 20 mg/mL Hyaluronic Acid Filler

Katie Beleznay, Jean Carruthers, Alastair Carruthers et al. · Dermatologic Surgery · 2015 · 146 citations

Medicine, Dermatology, Immunology +15